Prognostic significance of micropapillary pattern and risk factors in patients with resected stage I lung adenocarcinoma and possible benefit of adjuvant therapy: a real-world multicenter study
Li, Jianjie, Chi, Yujia, Jia, Bo, Zheng, Qiwen, Yuan, Minghan, Zhang, Jianjun, Zhou, Aishen, Sun, Wei, Yang, Yue, Zhao, Jun, An, Tongtong, Wang, Yuyan, Zhuo, Minglei, Yang, Xue, Chen, Hanxiao, Wang, Jingjing, Zhai, Xiaoyu, Tai, Yidi, He, Yuling, Kong, Lingdong, Ji, Xumeng, Liu, Yiliang, Wu, Nan, Onodera, Ken, Schil, Paul Van, Thomas, Mathew, Yang, Fan, Wang, Ziping
- ISSN / E-ISSN
- — / —
- DOI
- 10.21037/tlcr-2025-698 ↗
- Volume · Issue · Pages
- 14 · 7 · —
- Publisher
- AME Publishing Company
- Article URL
- https://tlcr.amegroups.org/article/view/103402 ↗
- Article details
- Unverified
Publication date (each date has its type and source)
31 Jul 2025
Publisher publication date · source: Journal websites (OAI-PMH feeds of Open Journal Systems)
| Type | Date | Source |
|---|---|---|
| Publisher publication date | 31 Jul 2025 | Journal websites (OAI-PMH feeds of Open Journal Systems) |
HEC Status at Publication Not the journal's current status
HEC Status at PublicationNot conclusive
Historical status could not be conclusively determined.
- Some rows of the HEC list for this period are not yet matched to a journal, so absence cannot be proved. Pending verification.
Best available information, not a definitive status: Some rows of the HEC list for this period are not yet matched to a journal, so absence cannot be proved. Pending verification.
- Journal
- Translational Lung Cancer Research
- Publication date used
- 31 Jul 2025 (Publisher publication date)
- Applicable HEC period
- 2024–25 (version 1) · 01 Oct 2024 – 31 Mar 2026
- Category
- —
- Recognition status
- Pending Verification (PERIOD_HAS_UNMATCHED_ROWS)
- Source
- —
- Verification status
- Unverified
This is an automatically generated summary based on the information available on the publication date. Terms & conditions apply.